Profile
Mediphage is developing safe and re-dosable non-viral gene therapies based on its proprietary linear, covalently closed and double-stranded mini-string DNA (msDNA) platform technology. Mediphage’s platform technology is versatile and confers applications in gene addition, in vivo gene editing and ex vivo gene editing for cell therapy approaches, plasmids for recombinant viral vector production and DNA vaccines.
Event details
Date: January 9 - 11, 2023
Event contact
Patricia Cosgrove
Area Director
USA: Life Sciences
Tel: +1 647-293-6306
Email: patricia.cosgrove@ontario.ca
Participants
13 in total
-
AmacaThera is a clinical-stage biotechnology company transforming therapeutics to make a difference in patient health.… -
Caladria is a precision neuromedicine company focused on using an unbiased human data-driven approach to discover and… -
Cloud DX provides award-winning Virtual Care and Remote Patient Monitoring (RPM) solutions to… -
ImmunoBiochem is an immuno-oncology biopharmaceutical company that has developed a disruptive approach to targeting… -
Mannin Research Inc. is a Canadian private biotechnology company, headquartered in Toronto, Ontario. It is developing… -
Mediphage is developing safe and re-dosable non-viral gene therapies based on its proprietary linear, covalently closed… -
Nucro-Technics is a full-service Contract Support Organization that specializes in the conduct of both… -
ProteinQure is a computational platform for protein drug discovery that partners with pharma to deliver experimentally… -
QurCan Therapeutics is a biotech company focused on developing next-generation RNA and chemotherapeutics… -
Quthero aims to disrupt skin care after dermatological procedures, such as laser skin resurfacing and microneedling,… -
Rapid Novor helps researchers decode immunity so they can rapidly and effortlessly develop diagnostics, therapies,… -
Spiderwort is a biomaterials company developing a platform of biocompatible, versatile, cellulose-based scaffolds for… -
Tenomix’s mission is to develop novel technologies that target inefficiencies in the pathology workflow, optimize…